Hereditary ATTR amyloidosis: recognizing early symptoms through narrative medicine

Hereditary transthyretin amyloidosis is a rare disease whose initial symptoms can be subtle and difficult to detect early. In this context, narrative medicine can become an important tool for improving patient care, diagnosis, and patient care. We discussed this with Dr. Vittoria Cianci, director of the Neurology Unit at the Grande Ospedale Metropolitano of Reggio Calabria, during the presentation of the "AMYCI" project, developed with AstraZeneca and the FAMY patient association.